{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:18:02Z","timestamp":1793395082181,"version":"4.5.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"This work was supported by the Kunming Health Science and Technology \"Thousand Project\" Talents Project:","award":["2021-SW (reserve)-08"],"award-info":[{"award-number":["2021-SW (reserve)-08"]}]},{"name":"Scientific Research Fund Project of Education Department of Yunnan Province","award":["2024J0277"],"award-info":[{"award-number":["2024J0277"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Implementing a full-sample prescription review system has become imperative for hospitals to address the limitations of post-review practices and ensure patient medication safety. In this study, we investigate the preliminary application impact of the prescription pre-review system (PPRS)and its rules maintenance in our hospital, while also evaluating the pharmaceutical service value resulting from the implementation of prescription pre-review.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We incorporated levels of prescribing warnings into the PPRS, while establishing and maintaining a database of appropriate medication practices. In addition, we evaluated the rationality of intravenous infusion prescriptions and key monitored drug prescriptions before and after the implementation of PPRS, and briefly evaluated the irrational prescriptions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A comprehensive range of 7 warning levels was established, reflective of the degree of prescription irrationality. Besides, a total of 3015 user rules were created to regulate medication behavior. The number and proportion of unreasonable prescriptions during January to March 2023 demonstrated a noteworthy reduction when compared to the corresponding period in 2022. Moreover, the continuous evaluation of systematic alert prescriptions during January to March 2023 indicated a remarkable monthly decline.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The introduction of the PPRS has ushered in a paradigm shift in the evaluation of prescription rationality. This transformative system has played a pivotal role in standardizing doctor\u2019s prescribing patterns, thereby promoting the rational utilization of drugs in clinical practice. By ensuring patient safety, elevating the quality of care, and enhancing the value of pharmacists, the PPRS has emerged as a catalyst for positive change in the healthcare setting.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12913-025-12901-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T07:39:36Z","timestamp":1751355576000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Establishment, maintenance and application effect analysis of the prescription pre-review system in a tertiary hospital in China"],"prefix":"10.1186","volume":"25","author":[{"given":"Li","family":"Zhou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feilong","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjing","family":"Duanmu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyi","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"1","key":"12901_CR1","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1186\/s12913-023-09931-5","volume":"23","author":"X Fan","year":"2023","unstructured":"Fan X, Chen D, Bao S, Dong X, Fang F, Bai R, Zhang Y, Zhang X, Tang W, Ma Y, et al. Prospective prescription review system correlated with more rational PPI medication use, better clinical outcomes and reduced PPI costs: experience from a retrospective cohort study. BMC Health Serv Res. 2023;23(1):1014.","journal-title":"BMC Health Serv Res"},{"issue":"4","key":"12901_CR2","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1001\/jamainternmed.2019.7064","volume":"180","author":"R Steinbrook","year":"2020","unstructured":"Steinbrook R. Decreasing medicare spending on prescription drugs. JAMA Intern Med. 2020;180(4):601.","journal-title":"JAMA Intern Med"},{"issue":"9","key":"12901_CR3","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jama.2020.0359","volume":"323","author":"C Deb","year":"2020","unstructured":"Deb C, Curfman G. Relentless prescription drug price increases. JAMA. 2020;323(9):826\u20138.","journal-title":"JAMA"},{"issue":"11","key":"12901_CR4","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/jamainternmed.2022.3946","volume":"182","author":"SM Desai","year":"2022","unstructured":"Desai SM, Chen AZ, Wang J, Chung WY, Stadelman J, Mahoney C, Szerencsy A, Anzisi L, Mehrotra A, Horwitz LI. Effects of Real-time prescription benefit recommendations on patient Out-of-Pocket costs: A cluster randomized clinical trial. JAMA Intern Med. 2022;182(11):1129\u201337.","journal-title":"JAMA Intern Med"},{"issue":"1","key":"12901_CR5","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/s12325-021-01935-z","volume":"39","author":"H Xie","year":"2022","unstructured":"Xie H, Zhang H, Peng J, Li L, Geng Y, Ge W. Prospective prescription review system promotes safe use of analgesics, improves clinical outcomes, and saves medical costs in surgical patients: insights from Nanjing drum tower hospital. Adv Ther. 2022;39(1):441\u201354.","journal-title":"Adv Ther"},{"issue":"1","key":"12901_CR6","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.tcm.2020.11.009","volume":"32","author":"PG Postema","year":"2022","unstructured":"Postema PG. Editorial commentary: choosing wisely: implications of drug prescription, drug safety assessment and tools for improvement. Trends Cardiovasc Med. 2022;32(1):50\u20131.","journal-title":"Trends Cardiovasc Med"},{"key":"12901_CR7","unstructured":"Ministry of Health of the PRC. Notice of the Ministry of Health on printing and distributing the Management Standard of Hospital Prescription Comment(Trial). 2010. [Accessed 6 Sept 2023]. http:\/\/www.nhc.gov.cn\/yzygj."},{"key":"12901_CR8","unstructured":"National Health Commission of the PRC. Drug Administration Law. 2009. [Accessed 1 Sept 2023]. http:\/\/www.nhc.gov.cn\/fzs."},{"key":"12901_CR9","unstructured":"Ministry of Health of the PRC. Decree of the Ministry of Health of the PRC No. 53: Prescription Administration Measures. 2007. [Accessed 1 Sept 2023]. http:\/\/www.nhc.gov.cn\/wjw."},{"issue":"16","key":"12901_CR10","doi-asserted-by":"publisher","first-page":"1352","DOI":"10.21037\/atm-20-7502","volume":"9","author":"J Bian","year":"2021","unstructured":"Bian J, Li Q, Li J, Yang N, Zhang W, Mei D, Zhong M, Miao L, Lu X, Jiang L, et al. Guideline for the evaluation of prescription appropriateness. Ann Transl Med. 2021;9(16):1352.","journal-title":"Ann Transl Med"},{"issue":"1","key":"12901_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1186\/s12913-022-07854-1","volume":"22","author":"X Tan","year":"2022","unstructured":"Tan X, Zhang J, Gu D, Ran S, Gu T, Lin X, Tao E, Asakawa T, Fang H. Evaluation of the reliability of the criteria for assessing prescription quality in Chinese hospitals among pharmacists in China. BMC Health Serv Res. 2022;22(1):455.","journal-title":"BMC Health Serv Res"},{"issue":"3","key":"12901_CR12","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s11096-022-01503-7","volume":"45","author":"A Spigelmyer","year":"2023","unstructured":"Spigelmyer A, Howard C, Rybakov I, Burwell S, Slain D. Impact of clinical pharmacist discharge prescription review on the appropriateness of antibiotic therapy: a retrospective comparison. Int J Clin Pharm. 2023;45(3):769\u201373.","journal-title":"Int J Clin Pharm"},{"key":"12901_CR13","unstructured":"National Health Commission of the PRC. Notice on the Issuance of prescription review Standards for Medical Institutions. 2018. [Accessed 6 Sept 2023]. http:\/\/www.nhc.gov.cn\/yzygj."},{"issue":"3","key":"12901_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.medmal.2018.10.002","volume":"49","author":"V P\u00e9rut","year":"2019","unstructured":"P\u00e9rut V, Gauzit R, Kern\u00e9is S, Canou\u00ef E, Chedhomme FX, Batista R, Conort O, Bouam S, Raymond J, Loubinoux J, et al. Assessing the benefit of the 72-hour antibiotic therapy reassessment Documentation. Med Maladies Infect. 2019;49(3):187\u201393.","journal-title":"Med Maladies Infect"},{"issue":"2","key":"12901_CR15","doi-asserted-by":"publisher","first-page":"e176","DOI":"10.1016\/j.japh.2020.12.008","volume":"61","author":"J Liu","year":"2021","unstructured":"Liu J, Zhang Y, Chen N, Li L, Wu Y, Guan C, Yang C, Lin H, Li Y. Remote pharmacy service in primary care: the implementation of a cloud-based pre-prescription review system. J Am Pharmacists Association: JAPhA. 2021;61(2):e176\u201382.","journal-title":"J Am Pharmacists Association: JAPhA"},{"issue":"3","key":"12901_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/j.jhin.2019.07.017","volume":"103","author":"ELA Cross","year":"2019","unstructured":"Cross ELA, Sivyer K, Islam J, Santillo M, Mowbray F, Peto TEA, Walker AS, Yardley L, Llewelyn MJ. Adaptation and implementation of the ARK (Antibiotic review Kit) intervention to safely and substantially reduce antibiotic use in hospitals: a feasibility study. J Hosp Infect. 2019;103(3):268\u201375.","journal-title":"J Hosp Infect"},{"issue":"10","key":"12901_CR17","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1080\/17512433.2022.2120468","volume":"15","author":"W Zuo","year":"2022","unstructured":"Zuo W, Sun Y, Liu R, Du L, Yang N, Sun W, Wang P, Tang X, Liu Y, Ma Y, et al. Management guideline for the off-label use of medicine in China (2021). Expert Rev Clin Phar. 2022;15(10):1253\u201368.","journal-title":"Expert Rev Clin Phar"},{"issue":"2","key":"12901_CR18","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1136\/ejhpharm-2017-001283","volume":"25","author":"Z Zheng","year":"2018","unstructured":"Zheng Z, Zeng Y, Huang H. Pharmacists\u2019 role in off-label drug use in China. Eur J Hosp Pharm. 2018;25(2):116.","journal-title":"Eur J Hosp Pharm"},{"issue":"2","key":"12901_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1136\/ejhpharm-2021-003187","volume":"30","author":"YJ Cheon","year":"2023","unstructured":"Cheon YJ, Ye KN, Park KH, Kim JB, Yoon JE, Lee MK, Kim JT, An SH. Implementation of pharmacists\u2019 monitoring for intravenous drug compatibility. Eur J Hosp Pharm. 2023;30(2):101\u20136.","journal-title":"Eur J Hosp Pharm"},{"issue":"8","key":"12901_CR20","doi-asserted-by":"publisher","first-page":"e1181","DOI":"10.1097\/PTS.0000000000001047","volume":"18","author":"JG Jessurun","year":"2022","unstructured":"Jessurun JG, Hunfeld NGM, van Rosmalen J, van Dijk M, van den Bemt P. Effect of a Pharmacy-based centralized intravenous admixture service on the prevalence of medication errors: A Before-and-After study. J Patient Saf. 2022;18(8):e1181\u20138.","journal-title":"J Patient Saf"},{"key":"12901_CR21","doi-asserted-by":"crossref","unstructured":"Gabay M, Hertig JB, Degnan D, Burger M, Yaniv A, McLaughlin M, Lynn Moody M. Third Consensus Development Conference on the Safety of Intravenous Drug Delivery Systems-2018. Am J Health Syst Pharm. 2020;77(3):215\u2013220.","DOI":"10.1093\/ajhp\/zxz277"},{"key":"12901_CR22","unstructured":"National Health Commission of the PRC. National Healthcare Quality and Safety Improvement Goals for 2023. [Accessed 2 Feb 2024]. http:\/\/www.nhc.gov.cn\/yzygj."},{"key":"12901_CR23","doi-asserted-by":"publisher","first-page":"9970063","DOI":"10.1155\/2021\/9970063","volume":"2021","author":"W Xiong","year":"2021","unstructured":"Xiong W, Cao J, Zhou X, Du J, Nie B, Zeng Z, Li T. Design and evaluation of a prescription drug monitoring program for Chinese patent medicine based on knowledge graph. Evid Based Complement Alternat Med. 2021;2021:9970063.","journal-title":"Evid Based Complement Alternat Med"},{"key":"12901_CR24","unstructured":"National Health Commission of the PRC. Procedures for Adjustment of the National Key Monitoring and Rational Use Drugs List. 2021. [Accessed 6 Sept 2023]. http:\/\/www.nhc.gov.cn\/yzygj."},{"key":"12901_CR25","doi-asserted-by":"publisher","first-page":"109887","DOI":"10.1016\/j.drugalcdep.2023.109887","volume":"247","author":"E Tay","year":"2023","unstructured":"Tay E, Makeham M, Laba TL, Baysari M. Prescription drug monitoring programs evaluation: A systematic review of reviews. Drug Alcohol Depend. 2023;247:109887.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"12901_CR26","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1097\/FTD.0000000000001067","volume":"45","author":"JP Telles","year":"2023","unstructured":"Telles JP, Morales R Jr., Yamada CH, Marins TA, D\u2019Amaro Juodinis V, Sztajnbok J, Silva M Jr., Bassetti BR, Albiero J, Tuon FF. Optimization of antimicrobial stewardship programs using therapeutic drug monitoring and Pharmacokinetics-Pharmacodynamics protocols: A Cost-Benefit review. Ther Drug Monit. 2023;45(2):200\u20138.","journal-title":"Ther Drug Monit"},{"issue":"4","key":"12901_CR27","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/dar.13431","volume":"41","author":"D Hoppe","year":"2022","unstructured":"Hoppe D, Karimi L, Khalil H. Mapping the research addressing prescription drug monitoring programs: A scoping review. Drug Alcohol Rev. 2022;41(4):803\u201317.","journal-title":"Drug Alcohol Rev"},{"issue":"10","key":"12901_CR28","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1016\/j.jiph.2020.06.035","volume":"13","author":"F Alogaili","year":"2020","unstructured":"Alogaili F, Abdul Ghani N, Ahmad Kharman Shah N. Prescription drug monitoring programs in the US: A systematic literature review on its strength and weakness. J Infect Public Health. 2020;13(10):1456\u201361.","journal-title":"J Infect Public Health"},{"key":"12901_CR29","doi-asserted-by":"publisher","first-page":"671","DOI":"10.2147\/PPA.S126647","volume":"11","author":"J Krska","year":"2017","unstructured":"Krska J, Katusiime B, Corlett SA. Validation of an instrument to measure patients\u2019 experiences of medicine use: the living with medicines questionnaire. Patient Prefer Adherence. 2017;11:671\u20139.","journal-title":"Patient Prefer Adherence"},{"issue":"5","key":"12901_CR30","first-page":"1049","volume":"43","author":"R Jin","year":"2018","unstructured":"Jin R, Zhao KJ, Guo GM, Zhang B, Wang YG, Xue CM, Yang YH, Wang LX, Li GH, Tang JF, et al. [Expert consensus on prescription comment of Chinese traditional patent medicine for promoting the rational use of drugs in Beijing]. Zhongguo Zhong Yao Za Zhi. 2018;43(5):1049\u201353.","journal-title":"Zhongguo Zhong Yao Za Zhi"},{"issue":"7","key":"12901_CR31","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.jaac.2019.03.030","volume":"58","author":"P Riggs","year":"2019","unstructured":"Riggs P. Editorial: prescription for addiction. J Am Acad Child Adolesc Psychiatry. 2019;58(7):659\u201360.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"1","key":"12901_CR32","doi-asserted-by":"publisher","first-page":"e006086","DOI":"10.1136\/bmjopen-2014-006086","volume":"5","author":"OO Shiyanbola","year":"2015","unstructured":"Shiyanbola OO, Mort JR. Patients\u2019 perceived value of pharmacy quality measures: a mixed-methods study. BMJ Open. 2015;5(1):e006086.","journal-title":"BMJ Open"},{"issue":"1","key":"12901_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41576-018-0061-7","volume":"20","author":"G Gibson","year":"2019","unstructured":"Gibson G. Going to the negative: genomics for optimized medical prescription. Nat Rev Genet. 2019;20(1):1\u20132.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"12901_CR34","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1186\/s12877-022-03107-2","volume":"22","author":"N Molist-Brunet","year":"2022","unstructured":"Molist-Brunet N, Sevilla-S\u00e1nchez D, Puigoriol-Juvanteny E, Barneto-Soto M, Gonz\u00e1lez-Bueno J, Espaulella-Panicot J. Improving individualized prescription in patients with Multimorbidity through medication review. BMC Geriatr. 2022;22(1):417.","journal-title":"BMC Geriatr"},{"issue":"3","key":"12901_CR35","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1038\/s41440-020-00598-7","volume":"44","author":"O Abrahin","year":"2021","unstructured":"Abrahin O. Comment on prescription of exercise training for hypertensives. Hypertens Res. 2021;44(3):363\u20134.","journal-title":"Hypertens Res"},{"issue":"2","key":"12901_CR36","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1177\/1715163518755813","volume":"151","author":"P Martin","year":"2018","unstructured":"Martin P, Tannenbaum C. A prototype for evidence-based pharmaceutical opinions to promote physician-pharmacist communication around deprescribing. Can Pharm J (Ott). 2018;151(2):133\u201341.","journal-title":"Can Pharm J (Ott)"},{"issue":"2","key":"12901_CR37","doi-asserted-by":"publisher","first-page":"67","DOI":"10.3233\/JRS-191025","volume":"31","author":"MS Adil","year":"2020","unstructured":"Adil MS, Sultana R, Khulood D. PRIME study: prescription review to impede medication errors. Int J Risk Saf Med. 2020;31(2):67\u201379.","journal-title":"Int J Risk Saf Med"},{"issue":"11","key":"12901_CR38","doi-asserted-by":"publisher","first-page":"1658","DOI":"10.1016\/j.jfma.2019.12.011","volume":"119","author":"MJ Hsieh","year":"2020","unstructured":"Hsieh MJ, Huang YW, Tsai YH, Feng JY, Su WJ. Improved appropriateness of anti-tuberculosis prescription by the expert prescription review program in Taiwan. J Formos Med Assoc. 2020;119(11):1658\u201365.","journal-title":"J Formos Med Assoc"},{"issue":"4","key":"12901_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.18433\/J3KK6C","volume":"16","author":"HK Chhina","year":"2013","unstructured":"Chhina HK, Bhole VM, Goldsmith C, Hall W, Kaczorowski J, Lacaille D. Effectiveness of academic detailing to optimize medication prescribing behaviour of family physicians. J Pharm Pharm Sci. 2013;16(4):511\u201329.","journal-title":"J Pharm Pharm Sci"},{"issue":"2","key":"12901_CR40","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jhqr.2020.09.006","volume":"36","author":"A de Lorenzo-Pinto","year":"2021","unstructured":"de Lorenzo-Pinto A, Garc\u00eda-S\u00e1nchez R, Ortega-Navarro C, de Miguel-Yanes JM. [Comments on prescription of antihypertensives pro re Nata]. J Healthc Qual Res. 2021;36(2):117\u20138.","journal-title":"J Healthc Qual Res"},{"key":"12901_CR41","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1159\/000431205","volume":"55","author":"GC Brown","year":"2016","unstructured":"Brown GC, Brown MM. Value-Based medicine and pharmacoeconomics. Dev Ophthalmol. 2016;55:381\u201390.","journal-title":"Dev Ophthalmol"},{"issue":"1","key":"12901_CR42","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s40273-021-01111-9","volume":"40","author":"R Milne","year":"2022","unstructured":"Milne R, Carswell C. CHEERS to 30 years of pharmacoeconomics. PharmacoEconomics. 2022;40(1):5\u20136.","journal-title":"PharmacoEconomics"},{"issue":"9","key":"12901_CR43","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1080\/13696998.2020.1772797","volume":"23","author":"RL Mendoza","year":"2020","unstructured":"Mendoza RL. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics. J Med Econ. 2020;23(9):915\u201322.","journal-title":"J Med Econ"},{"key":"12901_CR44","doi-asserted-by":"publisher","first-page":"765226","DOI":"10.3389\/fphar.2022.765226","volume":"13","author":"X Xiong","year":"2022","unstructured":"Xiong X, Jiang X, Lv G, Yuan J, Li M, Lu ZK. Evidence of Chinese herbal medicine use from an economic perspective: A systematic review of pharmacoeconomics studies over two decades. Front Pharmacol. 2022;13:765226.","journal-title":"Front Pharmacol"},{"key":"12901_CR45","doi-asserted-by":"publisher","first-page":"1210002","DOI":"10.3389\/fphar.2023.1210002","volume":"14","author":"FR Girardin","year":"2023","unstructured":"Girardin FR, Cohen K, Schwenkglenks M, Durand-Zaleski I, Editorial. Pharmacoeconomics in the era of health technology assessment and outcomes research to prioritize resource use, innovation and investment. Front Pharmacol. 2023;14:1210002.","journal-title":"Front Pharmacol"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12901-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-12901-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-12901-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T12:44:59Z","timestamp":1781613899000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-025-12901-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["12901"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-12901-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-3503115\/v1","asserted-by":"object"}]},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"28 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All methods were carried out in accordance with relevant guidelines and regulations. This study was approved by the Ethics Committee of The Affiliated Yan'an Hospital of Kunming Medical University (2024-004-01).The need for written informed consent was waived by the Ethics Committee of The Affiliated Yan'an Hospital of Kunming Medical University due to the retrospective nature of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"853"}}